Invention Grant
- Patent Title: Treatment of EBV and KHSV infection and associated abnormal cellular proliferation
-
Application No.: US14096166Application Date: 2013-12-04
-
Publication No.: US09382286B2Publication Date: 2016-07-05
- Inventor: Raymond F. Schinazi , Junxing Shi , Joyce D. Fingeroth , Erik Gustafson
- Applicant: EMORY UNIVERSITY , BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
- Applicant Address: US GA Atlanta US CA Boston
- Assignee: EMORY UNIVERSITY,BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
- Current Assignee: EMORY UNIVERSITY,BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
- Current Assignee Address: US GA Atlanta US CA Boston
- Agency: Andrews Kurth LLP
- Agent David Bradin
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/70 ; C07H19/06 ; A61K31/513 ; A61K31/7072 ; A61K45/06 ; C07D239/54 ; C07D405/04 ; C07D409/04
Abstract:
A method and composition for the treatment, prevention and/or prophylaxis of a host, and in particular, a human, infected with Epstein-Barr virus (EBV), is provided that includes administering an effective amount of a 5-substituted uracil nucleoside or its pharmaceutically acceptable salt or prodrug, optionally in a pharmaceutically acceptable diluent or excipient.
Public/Granted literature
- US20140336143A1 TREATMENT OF EBV AND KHSV INFECTION AND ASSOCIATED ABNORMAL CELLULAR PROLIFERATION Public/Granted day:2014-11-13
Information query
IPC分类:
